This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Generated Narrative: MedicationRequest
Resource MedicationRequest "medication-request-example-tucatinib"
status: active
intent: order
Concept |
tucatinib 150 MG Oral Tablet (RxNorm#2361290) |
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
authoredOn: 2020-03-12
requester: Practitioner/practitioner-owen-oncologist " ONCOLOGIST"
dosageInstruction
text: oral twice a day every day
timing: Starting 2020-04-01, Once
route: Oral route (qualifier value) (SNOMED CT#26643006)
doseAndRate
maxDosePerAdministration: 2